The Rushed Vaccine Now Comes With THIS Warning from the FDA


The mass vaccine distribution efforts undertaken by the Biden-Harris regime at the direction of Dr. Anthony Fauci of the U.S. National Institute of Allergy and Infectious Diseases took a serious blow on July 13th as reports flood in that the Food and Drug Administration requiring a warning be issued on the Johnson & Johnson COVID19 vaccine. The warning will state the injection has been linked to the rare autoimmune-neurological disorder: Guillain-Barre syndrome which causes the body’s immune system to attack the nerves.

According to The Washington Post who broke the story on July 12th,

“About 100 preliminary reports of Guillain-Barré have been detected in vaccine recipients after the administration of 12.8 million doses of the Johnson & Johnson vaccine in the United States, according to a companion statement from the Centers for Disease Control and Prevention, which monitors vaccine safety systems with the FDA. Of these reports, 95 were serious and required hospitalization, the FDA statement said. There was one death. Neither agency provided details about the death.”

The Vaccine Adverse Event Reporting System

CNBC reported that Johnson and Johnson released a statement and has been in discussions with the FDA and other regulators about the occurrences of Guillain-Barre syndrome, attempting to minimize the impact of the news.

“The chance of having this occur is very low, and the rate of reported cases exceeds the background rate by a small degree,” the company said. “We strongly support raising awareness of the signs and symptoms of rare events to ensure they can be quickly identified and effectively treated.”

According to a statement from the CDC, “Reports of GBS after receipt of the J&J/Janssen COVID-19 Vaccine in the Vaccine Adverse Event Reporting System (VAERS) are rare, but do likely indicate a small possible risk of this side effect following this vaccine,”

“These cases have largely been reported about two weeks after vaccination and mostly in males, many aged 50 years and older,”

An About-Face From What Fauci Said in January

Just six months ago in response to a letter coauthored by 13 leading experts in GBS and related disorders, Dr. Fauci spoke to Neurology Today to “set the record straight” saying that he “had misspoken in an early December newscast when he said that people who have had Guillain-Barré syndrome (GBS) should avoid the SARS-CoV-2 vaccines because they might trigger a recurrence of the disease.”

It seems that Dr. Fauci who said then “I do stand corrected”, now stands corrected again. And as reports of adverse effects of the various vaccines for COVID19 mount, more and more doubts are sown and confirmed. Americans who have so far refused to be subjected with their families to a rushed vaccine will continue to do so, vindicated. And those who were on the fence will decide against it.

What Is This Guillain-Barré Syndrome (GBS) The FDA Is Warning About?

Guillain-Barré Syndrome or GBS is a rare disorder that causes the human immune system to attack its own nervous system specifically targeting the myelin sheath which surrounds nerves. There is no known cure for GBS and the mortality rate is between 4-7%, however, 60-80% of patients recover the ability to walk in about six months. Some may experience long-term effects, like weakness, numbness, and fatigue.

Nerve and damaged myelin sheath

According to The Mayo Clinic in Arizona, Guillain-Barré Syndrome presents with the following symptoms,

“Tingling and weakness starting in your feet and legs and spreading to your upper body and arms. In about 10% of people with the disorder, symptoms begin in the arms or face. As Guillain-Barre syndrome progresses, muscle weakness can evolve into paralysis.

Signs and symptoms of Guillain-Barre syndrome may include:

  • Prickling, pins and needles sensations in your fingers, toes, ankles or wrists
  • Weakness in your legs that spreads to your upper body
  • Unsteady walking or inability to walk or climb stairs
  • Difficulty with facial movements, including speaking, chewing or swallowing
  • Double vision or inability to move eyes
  • Severe pain that may feel achy, shooting or cramplike and may be worse at night
  • Difficulty with bladder control or bowel function
  • Rapid heart rate
  • Low or high blood pressure
  • Difficulty breathing

People with Guillain-Barre syndrome usually experience their most significant weakness within two weeks after symptoms begin.”



Please enter your comment!
Please enter your name here